Nutcracker Therapeutics has developed a biotech platform that is designed to create mRNA-based therapeutic drug products. The company's platform integrates proprietary hardware and software with advancements in mRNA biochemistry and nanoparticle delivery to produce optimized therapies on biochips. This enables medical professionals to discover, develop, and manufacture complex mRNA therapies and vaccines, which can greatly enhance human health.

Investors Include:

Bluebird Ventures, ND Capital, A&E Investments, Altitude Life Science Ventures, ARCH Venture Partners, Qatar Investment Authority.

Collective explained in 2 minutes

Learn how Collective's solutions enable you to manage your risk and maximize your wealth

Learn more

Our available services for this company

Lifetime IncomeCharitable Remainder Trust

Tax SavingsDonor Advised Fund